Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BLUE - bluebird bio: Throwing My Thesis In The Can And Starting Over From Scratch


BLUE - bluebird bio: Throwing My Thesis In The Can And Starting Over From Scratch

  • bluebird continues to struggle with their gene therapy programs. The company announced that the FDA placed another clinical hold on one of their gene therapy programs.
  • The company recently reported their Q2 earnings which revealed a big miss on EPS and revenue. In addition, the company is closing up shop in Europe.
  • I expected 2021 to be a turnaround year, but the regulatory and commercial setbacks have forced me to throw my original BLUE thesis in the trash.
  • bluebird’s decision to spin-off their cell therapies into 2seventy bio completely changes my BLUE thesis and game plan. I reveal my revamped strategy.

For further details see:

bluebird bio: Throwing My Thesis In The Can And Starting Over From Scratch
Stock Information

Company Name: bluebird bio Inc.
Stock Symbol: BLUE
Market: NASDAQ
Website: bluebirdbio.com

Menu

BLUE BLUE Quote BLUE Short BLUE News BLUE Articles BLUE Message Board
Get BLUE Alerts

News, Short Squeeze, Breakout and More Instantly...